BSN Capital Partners’s GE HealthCare GEHC Stock Holding History

BSN Capital Partners’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-49,500	Closed	-$4M	–	31
2024 Q3	$4M	Buy	+49,500	New	+$4.15M	0.78%	38

Other funds holding GEHC

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

BSN Capital Partners's GEHC Position: Q4 2024 in Review

BSN Capital Partners sold out of GE HealthCare (GEHC) in Q4 2024, closing a stake of 49,500 shares — an estimated $4M sold.

BSN Capital Partners first reported a position in GEHC in Q3 2024 and held it in 1 quarter. The position peaked at $4M in Q3 2024. 1,327 funds tracked by Wall St. Rank hold GEHC as of Q4 2024.

BSN Capital Partners reported no remaining GE HealthCare position as of Q4 2024 after selling out during the quarter.
BSN Capital Partners sold 49,500 GE HealthCare shares in Q4 2024, an estimated $4M.
BSN Capital Partners first reported a position in GE HealthCare in Q3 2024 and held it in 1 quarter.
BSN Capital Partners's GE HealthCare position peaked at $4M in Q3 2024.
1,327 funds tracked by Wall St. Rank held GE HealthCare as of Q4 2024.

Based on BSN Capital Partners's 13F filing for Q4 2024, filed 28 Jan 2025.